About: A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2000 (uk) im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de) wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw) artículu científicu espublizáu en febreru de 2000 (ast) artikull shkencor i botuar më 01 shkurt 2000 (sq) scientific article published on 01 February 2000 (en)
publication date	wds:Q73402165-24C002EC-C571-4FB2-9032-D4D022D234CE
publication date	2000-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73402165-522D07D2-9A19-4C70-9E9D-2911A0BDDAA1
language of work or name	English
author name string	wds:Q73402165-00977A72-7CCA-45C9-8F8C-1DCBBAB16CD8 wds:Q73402165-1258C643-8DFB-41C5-946C-B47B72F90465 wds:Q73402165-37AFC842-D35A-4F0E-ADEE-A48B22C93900 wds:Q73402165-9F78DB1E-419F-4B7A-A7B0-B258EE9A8FFC
author name string	Hanafusa T Matsuzawa Y Miyagawa J Imagawa A
rdfs:label	A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (en) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (nl) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (sq)
skos:prefLabel	A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (en) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (nl) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (sq)
name	A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (en) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (nl) A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (sq)
title	wds:Q73402165-9DCECB48-2D3C-4468-86C4-046ADB7EC891
title	A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group (en)
page(s)	wds:Q73402165-A462B202-C590-45DC-99F4-83C74873AF24
page(s)	301-307
instance of	wds:Q73402165-DC7CBBFE-8303-4C05-81D9-6D9EE21EAEC0
instance of	scholarly article
main subject	wds:Q73402165-2CDA5AC9-BE07-4B83-BC39-17605502EE73
main subject	type-1 diabetes
PubMed ID	wds:Q73402165-4BF72B33-521E-4FA4-81E6-8C10C0CF0122
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10655528
PubMed ID	10655528
published in	wds:Q73402165-A5D645E3-3953-417D-81BF-1E1367468BFB
published in	The New England Journal of Medicine
issue	wds:Q73402165-1281612F-6E3E-46EE-8D9D-CE3E7B00FEEB
volume	wds:Q73402165-CDE85388-CFE3-4476-A388-0C084767F3DB
issue	5
volume	342
DOI	wds:Q73402165-B0379364-51A0-4531-8059-ED515B8E30D2
DOI	http://dx.doi.org/10.1056/NEJM200002033420501
DOI	10.1056/NEJM200002033420501
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73402165
is cites work of	Expression and regulation of chemokines in murine and human type 1 diabetes. Varying clinical presentations at onset of type 1 diabetes mellitus in children--epidemiological evidence for different subtypes of the disease? Severity at onset of childhood type 1 diabetes in countries with high and low incidence of the condition Type 1 diabetes in Japan Current knowledge of Japanese type 1 diabetic syndrome Etiopathogenesis of insulin autoimmunity Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese Fulminant type 1 diabetes in Korea: high prevalence among patients with adult-onset type 1 diabetes. Fulminant type 1 diabetes as an important exception to the new diagnostic criteria using HbA(1c)--response to the International Expert Committee Type 1 diabetes: new perspectives on disease pathogenesis and treatment Enterovirus infection, CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit: a mechanism of accelerated beta-cell failure in fulminant type 1 diabetes Lack of islet neogenesis plays a key role in beta-cell depletion in mice infected with a diabetogenic variant of coxsackievirus B4 High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes Autoimmune type 1 diabetes: resolved and unresolved issues Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol Glycated albumin to glycated hemoglobin ratio is a sensitive indicator of blood glucose variability in patients with fulminant type 1 diabetes Human pancreatic exocrine response to nutrients in health and disease Idiopathic Type 1 diabetes Report of the committee on the classification and diagnostic criteria of diabetes mellitus Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Challenges in diagnosing type 1 diabetes in different populations Viral infections and molecular mimicry in type 1 diabetes Distinct cell clusters touching islet cells induce islet cell replication in association with over-expression of Regenerating Gene (REG) protein in fulminant type 1 diabetes RIG-I- and MDA5-initiated innate immunity linked with adaptive immunity accelerates beta-cell death in fulminant type 1 diabetes Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset Fulminant type 1 diabetes in China: a case report and review of the literature The role of fecal elastase-1 in detecting exocrine pancreatic disease Frequency of ketoacidosis in newly diagnosed type 1 diabetic children Revascularization of transplanted pancreatic islets and role of the transplantation site. Acute recurrent pancreatitis: an autoimmune disease? Etiopathogenesis of type 1 diabetes mellitus: prognostic factors for the evolution of residual beta cell function Latent autoimmune diabetes in adults (LADA) Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012). Antibody to CMRF35-Like Molecule 2, CD300e A Novel Biomarker Detected in Patients with Fulminant Type 1 Diabetes Fulminant type 1 diabetes--an important subtype in East Asia T lymphocyte response against pancreatic beta cell antigens in fulminant Type 1 diabetes. CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes. Target cell defense prevents the development of diabetes after viral infection. Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes Virus infections in type 1 diabetes Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Beyond Genetics: What Causes Type 1 Diabetes Endogenous insulin secretion even at a very low level contributes to the stability of blood glucose control in fulminant type 1 diabetes Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes Nitric oxide generation and poly(ADP ribose) polymerase activation precede beta-cell death in rats with a single high-dose injection of streptozotocin Pancreatic beta and alpha cells are both decreased in patients with fulminant type 1 diabetes: a morphometrical assessment Class II HLA genotype in fulminant type 1 diabetes: A nationwide survey with reference to glutamic acid decarboxylase antibodies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software